The value of improving freshwater ecosystem services: South Carolina residents' willingness to pay for improved water quality.

Riverine ecosystems play a crucial role in providing essential services such as drinking water, food, recreation, and other aquatic resources. Yet, their capacity to deliver ecosystem services is threatened by rapid land use which modifies their ecological functions. While freshwater monitoring and restoration programs became more robust with technological advancement, the technical ecosystem indicators monitored by experts do not typically resonate with the public. Since public sentiments and preferences are crucial in conservation planning, we quantified households' mean willingness to pay (WTP) for riverine ecosystem services in South Carolina (SC) using a payment card approach. This technique in conducting a contingent valuation method allowed us to estimate mean WTP for five aquatic indicators. Findings revealed that households' monthly mean WTP is higher for indicators that can enhance recreational benefits, such as fish catch ($5.89- $6.58), species richness ($6.28- $6.72) and access ($6.75) compared to IBI ($5.74- $6.26) and instream flow quality ($5.34-6.06). When extrapolated to entire SC, the improvement of each indicator would translate to total benefits ranging between $131 to $165 million annually. The values computed from this study could serve as inputs for the computation of benefit-cost ratios of proposed freshwater programs. By incorporating households' WTP in the policy analysis, decision makers can prioritize programs that offer the greatest public benefit, while enhancing freshwater quality across the state.

Bcl-2 expression in cell lines breast cancer and death program.

Breast cancer is a hormone-dependence and heterogenic disease. Drug resistance is the main reason for the failure of breast cancer treatment. Combinatory medications are methods for treatment but they are not sufficient in action. However, new approaches like molecular therapy reveal a new insight into cancer treatment. Studies show that Bcl-2 gene family inhibitors and ER blockers cause the improvement of recovery. Interfering molecules such as antisense ones can inhibit the expression of Bcl-2 and push the cancer cells to apoptosis. Our team designed a new Antisense Oligonucleotide (ASO) based on Antisense oligo G3139. MCF-7 and MDA-MB-231 cell lines were used to evaluate cellular proliferation. Liposomes and cationic nano-complex (Niosome) are used to increase the cellular delivery of ASO and Tamoxifen. We also investigated the cytotoxicity and apoptotic effects of Tamoxifen, naked ASO and Nano-packed ASO. The results indicated significant down-regulation of the Bcl-2 gene and inhibition of MCF-7 and MDA-MB-231 cellular proliferation. Flow-cytometry showed early apoptosis in all cell groups. The newly designed ASO reduced the expression of the Bcl-2 gene. It also had a synergistic effect with the Tamoxifen. The cationic nano-complex (Niosome) was more efficient than the liposome in delivering designed oligo antisense Bcl-2 in the cancer cells.

An in silico comparative transcriptome analysis identifying hub lncRNAs and mRNAs in brain metastatic small cell lung cancer (SCLC).

Small cell lung cancer (SCLC) is a particularly lethal subtype of lung cancer. Metastatic lung tumours lead to most deaths from lung cancer. Predicting and preventing tumour metastasis is crucially essential for patient survivability. Hence, in the current study, we focused on a comprehensive analysis of lung cancer patients' differentially expressed genes (DEGs) on brain metastasis cell lines. DEGs are analysed through KEGG and GO databases for the most critical biological processes and pathways for enriched DEGs. Additionally, we performed protein-protein interaction (PPI), GeneMANIA, and Kaplan-Meier survival analyses on our DEGs. This article focused on mRNA and lncRNA DEGs for LC patients with brain metastasis and underlying molecular mechanisms. The expression data was gathered from the Gene Expression Omnibus database (GSE161968). We demonstrate that 30 distinct genes are up-expressed in brain metastatic SCLC patients, and 31 genes are down-expressed. All our analyses show that these genes are involved in metastatic SCLC. PPI analysis revealed two hub genes (CAT and APP). The results of this article present three lncRNAs, Including XLOC_l2_000941, LOC100507481, and XLOC_l2_007062, also notable mRNAs, have a close relation with brain metastasis in lung cancer and may have a role in the epithelial-mesenchymal transition (EMT) in tumour cells.

Diagnostic of Cytokeratin-19 Gene Expression in Iranian Breast Cancer Patients.

Sentinel lymph node (SLN) biopsy is currently the recommended procedure for axillary staging in clinically node-negative early breast cancer at diagnosis. The present study aimed to identify Cytokeratin-19 (CK19) gene profiles that accurately predicted the outcome of breast cancer patients. Fifty tumor samples from breast cancer patients were analyzed for the expression of the CK19 gene using quantitative PCR. Also, normal breast tissues (N = 50) were taken from the same patients that had undergone partial or total mastectomy. This gene signature was confirmed based on tumor's stage, grade, and estrogen receptor (ER) status, using conditional logistic regression. Based on these findings, the negative reported lymph nodes for metastasis had micrometastasis in significant values. There was a significant difference between normal and cancer samples in  CK19 expression. In this sentinel node evaluation, the relationship of this gene with tumor characteristics needs to be established and discussed finding a clear role for this gene in tumor outcome.

Valuing stakeholder preferences for environmental benefits of stormwater ponds: Evidence from choice experiment.

With population growth driving urban expansion in many cities in the United States, there is a need for a sustainable way to manage stormwater. Green stormwater infrastructure (GSI) is considered an innovative way to handle stormwater because of its potential to provide multiple ecosystem services (ES) beyond flooding reduction. However, there is limited research regarding the society's perceived value for GSI practices' co-benefits. This study utilized stated-preference data obtained from a choice experiment in an online survey of 1159 South Carolina (SC) residents to estimate a monetary value for the ES provided by wet detention ponds- the most widely adopted stormwater practice in coastal counties of SC. The benefits examined are flooding reduction, water quality, wildlife habitat, recreation, and scenic beauty. The data were analyzed using a Mixed logit formulation. Considering the differences across the state, the model was estimated separately for five counties. Findings indicate that residents are willing to pay $13.8 to $37.8 annually for a 50% improvement in pollutant removal efficiency of ponds in addition to their current stormwater fee. Also, they are willing to pay $12.5 to $42.9 per year for the nearest pond to have buffer vegetation and wildlife. They are also likely to pay $5 to $22.5 for ponds to contribute to their neighborhood's scenic beauty. Furthermore, the results indicate that respondents from three counties are willing to pay $5.4 to $13.2 for a 50% improvement in flooding reduction, while those from two counties are likely to pay $3.9 to $4.9 for ponds to have recreational benefits. The findings of the study could help stormwater managers in designing their stormwater management programs, especially for better evaluation of stormwater utility fees.

Using stakeholders' preference for ecosystems and ecosystem services as an economic basis underlying strategic conservation planning.

Ecosystem services (ES), commonly defined as the benefits people get from ecosystems, are key components in improving human well-being. However, as land utilization transitions from forest and agricultural land to urban areas and industrial complexes, the continuous provision of ES is affected. To ensure sustainable development, conservation programs should be implemented that consider both the stakeholders' well-being while also maintaining ecosystem health and integrity. Consequently, to improve the strategic implementation of conservation programs, it is critical to understand stakeholders' preferences. Using an online survey, we elicited South Carolina residents' preference in prioritizing the target ecosystems and ecosystem services in the state. The results identified that the priority ecosystem service is water quality regulation. However, the residents' preference for water quality regulation does not discredit the importance of maintaining the continuous water supply provision. In terms of ecosystem preference, residents indicated that the forest ecosystem is the priority ecosystem to be conserved, particularly for younger residents, respondents with high income, and those in the midland and the upstate. This could be attributed to the forest's effect on the ecosystem services that these respondents receive, particularly towards water-related ecosystem services. Understanding the residents' preference provides information that could improve the state water plans and other potential policy implications to land use-land cover planning and landscape sustainability management.

A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations.

In this study, the role of known Parkinson's disease (PD) genes was examined in families with autosomal recessive (AR) parkinsonism to assist with the differential diagnosis of PD. Some families without mutations in known genes were also subject to whole genome sequencing with the objective to identify novel parkinsonism-related genes. Families were selected from 4000 clinical files of patients with PD or parkinsonism. AR inheritance pattern, consanguinity, and a minimum of two affected individuals per family were used as inclusion criteria. For disease gene/mutation identification, multiplex ligation-dependent probe amplification, quantitative PCR, linkage, and Sanger and whole genome sequencing assays were carried out. A total of 116 patients (50 families) were examined. Fifty-four patients (46.55%; 22 families) were found to carry pathogenic mutations in known genes while a novel gene, not previously associated with parkinsonism, was found mutated in a single family (2 patients). Pathogenic mutations, including missense, nonsense, frameshift, and exon rearrangements, were found in Parkin, PINK1, DJ-1, SYNJ1, and VAC14 genes. In conclusion, variable phenotypic expressivity was seen across all families.

An economic inquisition of water quality trading programs, with a case study of Jordan Lake, NC.

A water quality trading (WQT) program was promulgated in North Carolina to address water quality issues related to nutrients in the highly urbanizing Jordan Lake Watershed. Although WQT programs are appealing in theory, the concept has not proved feasible in several attempts between point and nonpoint polluters in the United States. Many application hurdles that create wedges between success and failure have been evaluated in the literature. Most programs, however, face multiple hurdles; eliminating one may not clear a pathway to success. Therefore, we identify and evaluate the combined impact of four different wedges including baseline, transaction cost, trading ratio, and trading cost in the Jordan Lake Watershed program. Unfortunately, when applied to the Jordan Lake program, the analysis clearly shows that a traditional WQT program will not be feasible or address nutrient management needs in a meaningful way. The hurdles individually would be difficult to overcome, but together they appear to be unsurmountable. This analysis shows that there is enough information to pre-identify potential hurdles that could inform policy makers where, and how, the concept might work. It would have saved time, energy, and financial resources if North Carolina had done so before embarking to implement their program in the Jordan Lake Watershed.

RIT2 Polymorphisms: Is There a Differential Association?

Neurological disorders include a wide variety of mostly multifactorial diseases related to the development, survival, and function of the neuron cells. Single-nucleotide polymorphisms (SNPs) have been extensively studied in neurological disorders, and in a number of instances have been reproducibly linked to disease as risk factors. The RIT2 gene has been recently shown to be associated with a number of neurological disorders, such as Parkinson's disease (PD) and autism. In the study reported here, we investigated the association of the rs12456492 and rs16976358 SNPs of the RIT2 gene with PD, essential tremor (ET), autism, schizophrenia (SCZ), and bipolar disorder (BPD; total of 2290 patients), and 1000 controls, by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Significant association was observed between rs12456492 and two disorders, PD and ET, whereas rs16976358 was found to be associated with autism, SCZ, and BPD. Our findings are indicative of differential association between the RIT2 SNPs and different neurological disorders.

Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?

CONTEXT: Breast cancer is the most common cancer in women worldwide. Estrogen receptor (ER) positive breast cancer constitutes the majority of these cancers. Hormone therapy has significantly improved clinical outcomes for early- and late-stage hormone receptor positive breast cancer. Although most patients with early stage breast cancer are treated with curative intent, approximately 20% - 30% of patients eventually experience a recurrence. During the last two decades, there have been tremendous efforts to understand the biological mechanisms of hormone therapy resistance, with the ultimate goal of implementing new therapeutic strategies to improve the current treatments for ER positive breast cancer. Several mechanisms of hormone therapy resistance have been proposed, including genetic alterations that lead to altered ER expression or ERs with changed protein sequence. EVIDENCE ACQUISITION: A Pubmed search was performed utilizing various related terms. Articles over the past 20 years were analyzed and selected for review. RESULTS: On the basis of published studies, the frequencies of ESR1 (the gene encoding ER) mutations in ER positive metastatic breast cancer range from 11% to 55%. Future larger prospective studies with standardized mutation detection methods may be necessary to determine the true incidence of ESR1 mutations. ESR1 amplification in breast cancer remains a controversial issue, with numerous studies either confirmed or challenged the reports of ESR1 amplification. The combination of intra-tumor heterogeneity regarding ESR1 copy number alterations and low level ESR1 copy number increase may account for these discrepancies. CONCLUSIONS: While numerous unknown issues on the role of ESR1 mutations in advanced breast cancer remain, these new findings will certainly deepen current knowledge on molecular evolution of breast cancer and acquired resistance to hormone therapy.

The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson's disease in Iranian population.

Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. Both genetic and environmental factors are involved in the etiology of the disease. Many studies have revealed the susceptibility genes and variations for PD which need further confirmation. Here we evaluated the association of variations in SNCA, HUSEYO and CSMD1 genes with PD. A case-control study was conducted with 489 PD patients and 489 healthy controls. DNA was extracted from peripheral blood of all subjects and rs356220 and rs11931074 in SNCA, rs2338971 in HUSEYO and rs12681349 in CSMD1 were genotyped using PCR-RFLP method. The genotypes and allele frequencies were significantly different between case and control groups for rs356220, rs11931074 and rs2338971 but not for rs12681349. We provided further evidence that rs356220 is associated with increased risk of PD supporting previous studies in Caucasian-based and Japanese populations. The association of rs11931074 with decreased risk of PD was also significant. This study revealed the first evidence of the association of rs2338971 with increased risk of PD in the Iranian population. Nevertheless, these findings need further validation via more replication studies.

A genetic variant in CAMKK2 gene is possibly associated with increased risk of bipolar disorder.

A recent large-scale study have reported that rs1063843, a single nucleotide polymorphism located in the CAMKK2 gene is highly associated with schizophrenia in European and Han Chinese populations. Increasing evidences show that schizophrenia and bipolar disorder have some common genetic variance. Here, we evaluated the association of this variant with schizophrenia and bipolar disorder in Iranian population. Genomic DNA was extracted from peripheral blood of 500 schizophrenic patients, 500 bipolar patients and 500 normal controls and all were genotyped for the rs1063843 using a PCR-RFLP method. The allele frequency of rs1063843 was significantly different in both schizophrenia and bipolar patients comparing to control group. For the first time, we showed that rs1063843 is highly associated with bipolar disorder, although more replication studies are needed to confirm our findings. Our results also support the findings of previous studies suggesting a significant association between rs1063843 and schizophrenia.

Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population.

DNA variations in the fibroblast growth factor 20 gene have been reported to be associated with Parkinson's disease (PD). The rs12720208, a functional SNP located in the 3'UTR region of the gene, was reported as a risk factor for PD. A number of studies, which tried to replicate the result in different populations, failed to detect any associations. In this study, we genotyped rs2720208 SNP in 520 PD patients and 520 healthy controls both from Iran. Significant differences were found in allele and genotype frequencies between patients and controls (p<0.0001 for both). Our results suggest that the rs12720208 polymorphism may be a risk factor for PD in Iranian population.